Literature DB >> 34404088

Predicting potential small molecule-miRNA associations based on bounded nuclear norm regularization.

Xing Chen1, Chi Zhou2, Chun-Chun Wang2, Yan Zhao2.   

Abstract

Mounting evidence has demonstrated the significance of taking microRNAs (miRNAs) as the target of small molecule (SM) drugs for disease treatment. Given the fact that exploring new SM-miRNA associations through biological experiments is extremely expensive, several computing models have been constructed to reveal the possible SM-miRNA associations. Here, we built a computing model of Bounded Nuclear Norm Regularization for SM-miRNA Associations prediction (BNNRSMMA). Specifically, we first constructed a heterogeneous SM-miRNA network utilizing miRNA similarity, SM similarity, confirmed SM-miRNA associations and defined a matrix to represent the heterogeneous network. Then, we constructed a model to complete this matrix by minimizing its nuclear norm. The Alternating Direction Method of Multipliers was adopted to minimize the nuclear norm and obtain predicted scores. The main innovation lies in two aspects. During completion, we limited all elements of the matrix within the interval of (0,1) to make sure they have practical significance. Besides, instead of strictly fitting all known elements, a regularization term was incorporated to tolerate the noise in integrated similarities. Furthermore, four kinds of cross-validations on two datasets and two types of case studies were performed to evaluate the predictive performance of BNNRSMMA. Finally, BNNRSMMA attained areas under the curve of 0.9822 (0.8433), 0.9793 (0.8852), 0.8253 (0.7350) and 0.9758 ± 0.0029 (0.8759 ± 0.0041) under global leave-one-out cross-validation (LOOCV), miRNA-fixed LOOCV, SM-fixed LOOCV and 5-fold cross-validation based on Dataset 1(Dataset 2), respectively. With regard to case studies, plenty of predicted associations have been verified by experimental literatures. All these results confirmed that BNNRSMMA is a reliable tool for inferring associations.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  association prediction; bounded nuclear norm regularization; matrix completion; microRNA; small molecule

Mesh:

Substances:

Year:  2021        PMID: 34404088     DOI: 10.1093/bib/bbab328

Source DB:  PubMed          Journal:  Brief Bioinform        ISSN: 1467-5463            Impact factor:   11.622


  6 in total

1.  miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3.

Authors:  Hongyu Zhou; Nana Zhang
Journal:  Open Med (Wars)       Date:  2022-07-12

2.  Using BERT to identify drug-target interactions from whole PubMed.

Authors:  Jehad Aldahdooh; Markus Vähä-Koskela; Jing Tang; Ziaurrehman Tanoli
Journal:  BMC Bioinformatics       Date:  2022-06-21       Impact factor: 3.307

3.  Predicting circRNA-drug sensitivity associations via graph attention auto-encoder.

Authors:  Lei Deng; Zixuan Liu; Yurong Qian; Jingpu Zhang
Journal:  BMC Bioinformatics       Date:  2022-05-04       Impact factor: 3.307

4.  DRDB: A Machine Learning Platform to Predict Chemical-Protein Interactions towards Diabetic Retinopathy.

Authors:  Yu Wei; Ruili Zhang; Xiaoqiang Li; Zhonglin Li; Kaimin Guo; Shanshan Li; Li Yan; Qian Zhao; Baijian Qu; Wenjia Wang; Shuiping Zhou; He Sun; Jianping Lin; Yunhui Hu
Journal:  Oxid Med Cell Longev       Date:  2022-07-20       Impact factor: 7.310

Review 5.  A Systematic Review of Clinical Validated and Potential miRNA Markers Related to the Efficacy of Fluoropyrimidine Drugs.

Authors:  Xiaomeng Sun; Jiani Chen; Xintao Chen; Qianmin Gao; Wei Chen; Xun Zou; Feng Zhang; Shouhong Gao; Shi Qiu; Xiaoqiang Yue; Houshan Yao; Xuan Liu; Mingming Li
Journal:  Dis Markers       Date:  2022-08-23       Impact factor: 3.464

6.  Multitype drug interaction prediction based on the deep fusion of drug features and topological relationships.

Authors:  Li-Ping Kang; Kai-Biao Lin; Ping Lu; Fan Yang; Jin-Po Chen
Journal:  PLoS One       Date:  2022-08-29       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.